Education
About Us
Working with TipRanks
Follow Us
Steris (STE)
NYSE:STE
STE Stock Chart & Stats
$263.77
$1.96(0.95%)
At close: 4:00 PM EST
$263.77
$1.96(0.95%)
Day’s Range― - ―
52-Week Range$204.90 - $269.44
Previous CloseN/A
Volume53.54K
Average Volume (3M)447.87K
Market Cap
$23.93B
Enterprise Value$26.31B
Total Cash (Recent Filing)$423.70M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)33.7
Beta0.40
Next Earnings
May 20, 2026EPS Estimate
2.86Next Dividend Ex-DateN/A
Dividend Yield0.94%
Share Statistics
EPS (TTM)2.53
Shares Outstanding98,147,010
10 Day Avg. Volume576,066
30 Day Avg. Volume447,865
Financial Highlights & Ratios
PEG Ratio0.58
Price to Book (P/B)3.38
Price to Sales (P/S)4.09
P/FCF Ratio28.72
Enterprise Value/Market Cap1.10
Enterprise Value/Revenue4.51
Enterprise Value/Gross Profit10.23
Enterprise Value/Ebitda19.30
Forecast
1Y Price Target
$295.50Price Target Upside12.03% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Cash GenerationManagement raised free cash flow guidance, reflecting improved cash generation and greater balance-sheet flexibility.
ProfitabilityReported gross and operating margins expanded and topped consensus, indicating improving profitability across key segments such as Healthcare and Life Sciences.
Revenue And GuidanceRevenue modestly exceeded consensus while earnings matched expectations, and management raised organic revenue and earnings-per-share guidance for the fiscal year, signaling stronger top-line momentum.
Bears Say
Segment Growth SlowdownOrganic revenue growth slowed as sales softened in the Healthcare and Life Sciences businesses, weakening the company's overall growth trajectory.
Tariff-related Cost PressureManagement increased the estimated tariff impact, including an expected $45 million headwind for the fiscal year, adding pressure to margins and operating costs.
Valuation RiskAnalyst's recommendation is Hold due to valuation concerns, which could reduce investor appetite until valuation metrics improve.
Steris News
STE FAQ
What was Steris’s price range in the past 12 months?
Steris lowest stock price was $204.90 and its highest was $269.44 in the past 12 months.
What is Steris’s market cap?
Steris’s market cap is $23.93B.
When is Steris’s upcoming earnings report date?
Steris’s upcoming earnings report date is May 20, 2026 which is in 102 days.
How were Steris’s earnings last quarter?
Steris released its earnings results on Feb 04, 2026. The company reported $2.53 earnings per share for the quarter, missing the consensus estimate of $2.532 by -$0.002.
Is Steris overvalued?
According to Wall Street analysts Steris’s price is currently Undervalued.
Does Steris pay dividends?
Steris pays a Quarterly dividend of $0.63 which represents an annual dividend yield of 0.94%. See more information on Steris dividends here
What is Steris’s EPS estimate?
Steris’s EPS estimate is 2.86.
How many shares outstanding does Steris have?
Steris has 98,147,010 shares outstanding.
What happened to Steris’s price movement after its last earnings report?
Steris reported an EPS of $2.53 in its last earnings report, missing expectations of $2.532. Following the earnings report the stock price went down -7.742%.
Which hedge fund is a major shareholder of Steris?
Currently, no hedge funds are holding shares in STE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Steris Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$295.50 (12.03% Upside)
$295.50 (12.03% Upside)
Blogger Sentiment
Bullish
STE Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 171.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $6.6M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 9.3%
Last 30 Days ▼ 9.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
11.51%
12-Months-Change
Fundamentals
Return on Equity
10.43%
Trailing 12-Months
Asset Growth
5.83%
Trailing 12-Months
Company Description
Steris
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
STE Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented solid top-line growth, EPS expansion, strong segment-level performance (notably AST capital equipment and healthcare services), and maintained full-year guidance — indicating operational resilience. However, meaningful margin pressure from tariffs and inflation, a notable gross margin decline, and seasonal/timing risks for the fourth quarter temper the outlook. Management is actively pursuing mitigation efforts and remains disciplined on capital and M&A. Overall, positives (revenue, EPS, segment momentum, backlog, leverage) outweigh the headwinds (tariffs, margin compression, near-term volatility).View all STE earnings summariesSTE Revenue Breakdown
73.00% U.S.
25.39% Other locations
1.61% Ireland
STE Stock 12 Month Forecast
Average Price Target
$295.50
▲(12.03% Upside)
Technical Analysis
Ownership Overview
0.30% Insiders
27.47% Mutual Funds
0.42% Other Institutional Investors
44.44% Public Companies and
Individual Investors